A PHASE 3, DOUBLE-BLIND, RANDOMIZED, EFFICACY AND SAFETY COMPARISON OF PRASUGREL AND PLACEBO IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE

Registry ID

H7T-MC-TADO

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

ELI LILLY CANADA INC

Start date

2014-09-04

Last update

2013-04-24

Conditions

• SICKLE CELL ANEMIA

Related clinical trials

• OPTIMA STUDY : OPTIMIZING HYDROXYUREA DOSAGE WITH PHARMAKOKINETIC IN PATIENTS SUFFERING OF MODERATE TO SEVERE SICKLE CELL ANEMIA.
• A VITAMIN D INTERVENTION IN CHILDREN WITH SICKLE CELL DISEASE: A PILOT RANDOMISED CONTROLLED TRIAL

View on source registry